Related Experiment Videos
Prehospital thrombolysis: an idea whose time has come.
C P Cannon1, A J Sayah, R M Walls
1Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Clinical Cardiology
|September 24, 1999
Summary
Rapid reperfusion therapy is crucial for ST-segment elevation myocardial infarction (MI) outcomes. Reducing patient and prehospital delays in administering this time-sensitive treatment significantly improves patient survival.
Area of Science:
- Cardiology
- Emergency Medicine
- Public Health
Background:
- Acute ST-segment elevation myocardial infarction (MI) requires prompt reperfusion therapy for optimal patient outcomes.
- Thrombolytic therapy effectiveness is time-dependent, with greatest benefits occurring earlier after symptom onset.
- Rapid identification and treatment are key goals in prehospital and emergency department care for acute MI.
Purpose of the Study:
- To review the rationale for rapid reperfusion in acute MI.
- To identify factors contributing to time delays in patient presentation and treatment.
- To explore strategies for minimizing prehospital delays in acute MI management.
Main Methods:
- Literature review focusing on prehospital management of acute MI.
- Analysis of time delays in the patient pathway from symptom onset to reperfusion.
- Discussion of patient- and system-based strategies to reduce treatment delays.
Main Results:
- Patient delays in seeking care are a more significant factor than prehospital system delays.
- Early administration of reperfusion therapy is directly correlated with improved patient outcomes.
- System-level interventions can help mitigate delays in emergency medical services.
Conclusions:
- Aggressive reperfusion therapy is vital for improving outcomes in ST-segment elevation MI.
- Reducing time to treatment, particularly patient-initiated delays, is critical for maximizing therapeutic benefit.
- A multi-faceted approach addressing both patient and prehospital factors is necessary to optimize acute MI care.